Literature DB >> 8342741

Position paper: Immunotherapy.

.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8342741     DOI： 10.1111/j.1398-9995.1993.tb04754.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  13 in total

Review 1.  New insights in sublingual immunotherapy.

Authors:  Giovanni Passalacqua; Laura Guerra; Enrico Compalati; Federica Fumagalli; Arianna Cirillo; Giorgio Walter Canonica
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

2.  Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany.

Authors:  P K Schädlich; J G Brecht
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 3.  T-cell responses induced by allergen-specific immunotherapy.

Authors:  E Maggi
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

Review 4.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Immunotherapy in all aspects.

Authors:  Deniz Hanci; Ethem Şahin; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

6.  Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.

Authors:  Clara Padró; Diego Gutiérrez; Francisco Moreno; Antonio Parra; Manuel J Rial; Ramón Lleonart; Carla Torán-Barona; José L Justicia; Albert Roger
Journal:  Immun Inflamm Dis       Date:  2022-05

7.  Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.

Authors:  R Bheekha Escura; E Wasserbauer; F Hammerschmid; A Pearce; P Kidd; G C Mudde
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

8.  Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients.

Authors:  Juliane Rieker-Schwienbacher; Marja J Nell; Zuzana Diamant; Ronald van Ree; Andreas Distler; Johan D Boot; Jörg Kleine-Tebbe
Journal:  Clin Transl Allergy       Date:  2013-05-08       Impact factor: 5.871

9.  Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients.

Authors:  Gabriel Gastaminza; Jaime Algorta; Olga Uriel; Maria T Audicana; Eduardo Fernandez; Maria L Sanz; Daniel Muñoz
Journal:  Trials       Date:  2011-08-09       Impact factor: 2.279

10.  Allergen-specific immunotherapy in patients 55 years and older: results and review of literature.

Authors:  Eduardo Baptistella; Sergio Maniglia; Diego Augusto Malucelli; Daniel Rispoli; Thanara Pruner de Silva; Fernanda Miyoko Tsuru; Renata Vecentin Becker; Gustavo Bernardi; Daniela Dranka; Bruno Ferraz
Journal:  Int Arch Otorhinolaryngol       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.